MRI in nonischemic acquired heart disease

Journal of Magnetic Resonance Imaging

Volumn 27, Issue 6, 2008, Pages 1195-1213

  Ordovás, Karen G ^a   Reddy, Gautham P ^a   Higgins, Charles B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acquired heart disease; Cardiac imaging; Cardiac MRI; Heart; Magnetic resonance

Indexed keywords

GADOLINIUM CHELATE;

BLOOD FLOWMETRY; CARDIOMYOPATHY; CINERADIOGRAPHY; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE CARDIOMYOPATHY; CONSTRICTIVE PERICARDITIS; CONTRAST ENHANCEMENT; ECHOCARDIOGRAPHY; HEART AMYLOIDOSIS; HEART DISEASE; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE DYSPLASIA; HEART RIGHT VENTRICLE FUNCTION; HEART TUMOR; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAGNETIC RESONANCE ANGIOGRAPHY; MYOCARDIAL DISEASE; MYOCARDITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PERICARDIAL DISEASE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RADIOCARDIOGRAPHY; RADIODIAGNOSIS; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SARCOIDOSIS; THREE DIMENSIONAL IMAGING; VALVULAR HEART DISEASE;

ELECTROCARDIOGRAPHY; HEART DISEASES; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MYOCARDIUM; VENTRICULAR FUNCTION;

EID: 44449140508     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.21172     Document Type: Review

References (76)

1. Lamb HJ, Kozerke S, Doornbos J, Bax JJ, de Roos A. Clinical approach to cardiovascular magnetic resonance techniques. In: Higgins CB, de Roos A, editors. MRI and CT of the cardiovascular system, 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 2006:1-18.
2. Kondo C, Caputo GR, Semelka R, Foster E, Shimakawa A, Higgins CB. Right and left ventricular stroke volume measurements with velocity-encoded cine MR imaging: in vitro and in vivo validation. AJR Am J Roentgenol 1991;157:9-16.
3. Carrol CL, Higgins CB, Caputo GR. Magnetic resonance imaging of acquired cardiac disease. Tex Heart Inst J 1996;23:144-154.
4. Mostbeck GH, Caputo GR, Higgins CB. MR measurement of blood flow in the cardiovascular system. AJR Am J Roentgenol 1992;159: 453-461.
5. Saeed M, Higgins CB. Magnetic resonance contrast media. In: Higgins CB, De Roos A, editors. MRI and CT of the cardiovascular system, 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 2006:107-120.
6. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the American Heart Association. Int J Cardiovasc Imaging 2002;18:539-542.
7. Dulce MC, Mostbeck GH, Friese KK, Caputo GR, Higgins CB. Quantification of the left ventricular volumes and function with cine MR imaging: comparison of geometric models with three-dimensional data. Radiology 1993;188:371-376.
8. Heusch A, Koch JA, Krogmann ON, Korbmacher B, Bourgeois M. Volumetric analysis of the right and left ventricle in a porcine heart model: comparison of three-dimensional echocardiography, magnetic resonance imaging and angiocardiography. Eur J Ultrasound 1999;9:245-255.
9. Sechtem U, Pflugfelder PW, Gould RG, Cassidy MM, Higgins CB. Measurement of right and left ventricular volumes in healthy individuals with cine MR imaging. Radiology 1987;163:697-702.
10. Bogaert J, Dymarkowski S, Herregods M, Taylor AM. Valvular heart disease. In: Higgins CB, De Roos A, editors. MRI and CT of the cardiovascular system. 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 2006:183-197.
11. Friedrich MG, Wassmuth R. Magnetic resonance of cardiomyopathies and myocarditis. In: Higgins CB, de Roos A, editors. MRI and CT of the cardiovascular system. 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 2006:121-136.
12. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996;93:841-842.
13. Wigle ED. Cardiomyopathy: the diagnosis of hypertrophic cardiomyopathy. Heart 2001;86:709-714.
14. Higgins CB, Byrd BF 3rd, Stark D, et al. Magnetic resonance imaging in hypertrophic cardiomyopathy. Am J Cardiol 1985;55:1121-1126.
15. van Dockum WG, ten Cate FJ, ten Berg JM, et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 2004;43:27-34.
16. Park JH, Kim YM, Chung JW, Park YB, Han JK, Han MC. MR imaging of hypertrophic cardiomyopathy. Radiology 1992;185:441-446.
17. Bogaert J, Goldstein M, Tannouri F, Golzarian J, Dymarkowski S. Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. AJR Am J Roentgenol 2003;180:981-985.
18. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-1474.
19. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-1567.
20. Hunold P, Schlosser T, Vogt FM, et al. Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol 2005;184:1420-1426.
21. Sachdev B, Takenaka T, Teraguchi H, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 2002;105:1407-1411.
22. Moon JC, Sheppard M, Reed E, Lee P, Elliott PM, Pennell DJ. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 2006;8:479-482.
23. Moon JC, Sachdev B, Elkington AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24:2151-2155.
24. von Schulthess GK, Fisher M, Crooks LE, Higgins CB. Gated MR imaging of the heart: intracardiac signals in patients and healthy subjects. Radiology 1985;156:125-132.
25. Estornell J, Echanove I, Payá R, L Pérez J, V Vilar J, Montero B. [Endomyocardial fibrosis. Presentation as a right ventricular tumor]. Rev Esp Cardiol 2001;54:655-657. [Spanish]
26. Cury RC, Abbara S, Sandoval LJ, Houser S, Brady TJ, Palacios IF. Images in cardiovascular medicine. Visualization of endomyocardial fibrosis by delayed-enhancement magnetic resonance imaging. Circulation 2005;111:e115-e117.
27. Maceira AM, Joshi J, Prasad SK, et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 2005;111:186-193.
28. Smedema JP, Snoep G, van Kroonenburgh MP, et al. The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis. Chest 2005;128:1629-1637.
29. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation 2003;108:1945-1953.
30. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001;22:2171-2179.
31. Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up of 34 adults with isolated left ventricular non-compaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36:493-500.
32. Petersen SE, Selvanayagam JB, Wiesmann F, et al. Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;46:101-105.
33. Daimon Y, Watanabe S, Takeda S, Hijikata Y, Komuro I. Two-layered appearance of noncompaction of the ventricular myocardium on magnetic resonance imaging. Circ J 2002;66:619-621.
34. Jassal DS, Nomura CH, Neilan TG, et al. Delayed enhancement cardiac MR imaging in noncompaction of left ventricular myocardium. J Cardiovasc Magn Reson 2006;8:489-491.
35. Kayser HW, van der Wall EE, Sivananthan MU, Plein S, Bloomer TN, de Roos A. Diagnosis of arrhythmogenic right ventricular dysplasia: a review. Radiographics 2002;22:639-648; discussion 649-650.
36. Buser PT, Keller DI, Bremerich J. Arrhythmogenic right ventricular cardiomyopathy. In: Higgins CB, De Roos A, editors. MRI and CT of the cardiovascular system, 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 2006:154-161.
37. Tandri H, Castillo E, Ferrari VA, et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006;48:2277-2284.
38. Tandri H, Saranathan M, Rodriguez ER, et al. Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol 2005;45:98-103.
39. Bluemke DA, Krupinski EA, Ovitt T, et al. MR Imaging of arrhythmogenic right ventricular cardiomyopathy: morphologic findings and interobserver reliability. Cardiology 2003;99:153-162.
40. Mahrholdt H, Wagner A, Deluigi CC, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 2006;114:1581-1590.
41. Friedrich MG, Strohm O, Schulz-Menger J, Marciniak H, Luft FC, Dietz R. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. Circulation 1998;97:1802-1809.
42. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109:1250-1258.
43. Frank H, Globits S. Magnetic resonance imaging evaluation of myocardial and pericardial disease. J Magn Reson Imaging 1999; 10:617-626.
44. Stark DD, Higgins CB, Lanzer P, et al. Magnetic resonance imaging of the pericardium: normal and pathologic findings. Radiology 1984;150:469-474.
45. Smith WH, Beacock DJ, Goddard AJ, Bloomer TN, Ridgway JP, Sivananthan UM. Magnetic resonance evaluation of the pericardium. Br J Radiol 2001;74:384-392.
46. Axel L. Assessment of pericardial disease by magnetic resonance and computed tomography. J Magn Reson Imaging 2004;19:816-826.
47. Wang ZJ, Reddy GP, Gotway MB, Yeh BM, Hetts SW, Higgins CB. CT and MR imaging of pericardial disease. Radiographics 2003; 23(Spec No):S167-S180.
48. Seelos KC, Funari M, Chang JM, Higgins CB. Magnetic resonance imaging in acute and subacute mediastinal bleeding. Am Heart J 1992;123:1269-1272.
49. Sechtem U, Tscholakoff D, Higgins CB. MRI of the abnormal pericardium. AJR Am J Roentgenol 1986;147:245-252.
50. Gutierrez FR, Shackelford GD, McKnight RC, Levitt RG, Hartmann A. Diagnosis of congenital absence of left pericardium by MR imaging. J Comput Assist Tomogr 1985;9:551-553.
51. Fowler NO. Constrictive pericarditis: its history and current status. Clin Cardiol 1995;18:341-350.
52. Myers RB, Spodick DH. Constrictive pericarditis: clinical and pathophysiologic characteristics. Am Heart J 1999;138:219-232.
53. Troughton RW, Asher CR, Klein AL. Pericarditis. Lancet 2004;363: 717-727.
54. Rienmuller R, Groll R, Lipton MJ. CT and MR imaging of pericardial disease. Radiol Clin North Am 2004;42:587-601, vi.
55. Hancock EW. Differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis. Heart 2001;86:343-349.
56. Masui T, Finck S, Higgins CB. Constrictive pericarditis and restrictive cardiomyopathy: evaluation with MR imaging. Radiology 1992; 182:369-373.
57. Kojima S, Yamada N, Goto Y. Diagnosis of constrictive pericarditis by tagged cine magnetic resonance imaging. N Engl J Med 1999; 341:373-374.
58. Giorgi B, Mollet NR, Dymarkowski S, Rademakers FE, Bogaert J. Clinically suspected constrictive pericarditis: MR imaging assessment of ventricular septal motion and configuration in patients and healthy subjects. Radiology 2003;228:417-424.
59. Ordovás KG, Reddy G, Sharp MJ, Weber OM, Higgins CB. MRI evaluation of ventricular septal motion abnormality (septal bounce): differentiation of constrictive pericarditis from restrictive cardiomyopathy. Radiology 2004;233(P):668.
60. Francone M, Dymarkowski S, Kalantzi M, Bogaert J. Real-time cine MRI of ventricular septal motion: a novel approach to assess ventricular coupling. J Magn Reson Imaging 2005;21:305-309.
61. Francone M, Dymarkowski S, Kalantzi M, Rademakers FE, Bogaert J. Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy. Eur Radiol 2006;16:944-951.
62. Funari M, Fujita N, Peck WW, Higgins CB. Cardiac tumors: assessment with Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 1991;15:953-958.
63. Kronbach GA, Saeed M, Higgins CB. Cardiac masses. In: Higgins CB, De Roos A, editors. MRI and CT of the cardiovascular system, 2nd edition. Philadelphia: Lippincott Williams & Wilkins, 2006: 162-182.
64. Hoffmann U, Globits S, Frank H. Cardiac and paracardiac masses. Current opinion on diagnostic evaluation by magnetic resonance imaging. Eur Heart J 1998;19:553-563.
65. Grebenc ML, Rosado de Christenson ML, Burke AP, Green CE, Galvin JR. Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation. Radiographics 2000;20:1073-1103; quiz 1110-1071, 1112.
66. Burke A, Virmani R. Tumors of the heart and great vessels. Atlas of tumor pathology, 3rd ser, Fasc 16. Washington, DC: Armed Forces Institute of Pathology, 1996. 231 p.
67. Glockner JF, Johnston DL, McGee KP. Evaluation of cardiac valvular disease with MR imaging: qualitative and quantitative techniques. Radiographics 2003;23:e9.
68. Dulce MC, Mostbeck GH, O'Sullivan M, Cheitlin M, Caputo GR, Higgins CB. Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging. Radiology 1992;185:235-240.
69. Fujita N, Chazouilleres AF, Hartiala JJ, et al. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol 1994;23:951-958.
70. Hundley WG, Li HF, Willard JE, et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques. Circulation 1995;92:1151-1158.
71. Kizilbash AM, Hundley WG, Willett DL, Franco F, Peshock RM, Grayburn PA. Comparison of quantitative Doppler with magnetic resonance imaging for assessment of the severity of mitral regurgitation. Am J Cardiol 1998;81:792-795.
72. Westenberg JJ, Doornbos J, Versteegh MI, et al. Accurate quantitation of regurgitant volume with MRI in patients selected for mitral valve repair. Eur J Cardiothorac Surg 2005;27:462-466; discussion 467.
73. Caruthers SD, Lin SJ, Brown P, et al. Practical value of cardiac magnetic resonance imaging for clinical quantification of aortic valve stenosis: comparison with echocardiography. Circulation 2003;108:2236-2243.
74. John AS, Dill T, Brandt RR, et al. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J Am Coll Cardiol 2003;42:519-526.
75. Blyth KG, Groenning BA, Martin TN, et al. Contrast enhanced- cardiovascular magnetic resonance imaging in patients with pulmonary hypertension. Eur Heart J 2005;26:1993-1999.
76. Kreitner KF, Ley S, Kauczor HU, et al. Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 2004;232:535-543.